<DOC>
	<DOCNO>NCT01051271</DOCNO>
	<brief_summary>ABSTRACT Study Objective : To compare effect midazolam diphenhydramine prevention metoclopramide induce akathisia . Methods : This randomize , double-blind control trial aim investigate co-administered midazolam versus diphenhydramine prophylaxis metoclopramide induce akathisia . Patients 18 65 year age present ED primary secondary complaint nausea and/or moderate severe vascular type headache eligible study . Patients randomize one fallowing three group : ( 1 ) metoclopramide 10 mg + midazolam 1.5 mg ( 2 ) metoclopramide 10 mg + diphenhydramine 20 mg ( 3 ) metoclopramide 10 mg + placebo . Metoclopramide administer 2 minute bolus infusion . Midazolam , diphenhydramine normal saline solution administer 15 minute slow infusion . Whole procedure observe , akathisia sedation score vital change record .</brief_summary>
	<brief_title>Prophylaxis Against Metoclopramide-Induced Akathisia</brief_title>
	<detailed_description />
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Patients 18 65 year age 5090 kg weight present ED primary secondary complaint nausea and/or moderate severe vascular type headache eligible study . Patients liver renal insufficiency Electrolyte imbalance Acute respiratory symptom Chronic obstructive pulmonary disease Blood pressure le 90/60 mmHg Uncooperative individual Pregnant lactate Preexisting motor disorder Restless legs syndromeparkinson 's disease Organic brain disorder , ( dementia etc . ) , epilepsy Admitted ED due acute psychiatric symptom Deprived mental status Advanced hearing loss Malnutrition Acute asthma attack Serious physical illness , especially glaucoma , prostatic hypertrophy , cardiac disease Had contraindication anticholinergic medication Within 3 day study entry patient take antiemetic antihistaminic , antipsychotic , antispasmodic , alphablocker , Ca++2channel blocker , within 2 week study entry patient take antidepressant , barbiturate , benzodiazepine , sedative/hypnotic , opioid , lithium , illicit sympathomimetic agent exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>metoclopramide</keyword>
	<keyword>akathisia</keyword>
	<keyword>midazolam</keyword>
	<keyword>diphenhydramine</keyword>
	<keyword>metoclopramide induced akathisia</keyword>
</DOC>